Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study

Kameda, Hideto; Takeuchi, Tsutomu; Yamaoka, Kunihiro; Oribe, Motohiro; Kawano, Mitsuhiro; Zhou, Yijie; A. Othman, Ahmed; L. Pangan, Aileen; Kitamura, Susumu; Meerwein, Sebastian; Tanaka, Yoshiya

doi:10.1093/rheumatology/keaa084

Public

Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study

Published in Lara D. Veeken • Feb 14, 2020

Authors:

Hideto Kameda

Tsutomu Takeuchi

Kunihiro Yamaoka

Abstract

OBJECTIVE: To evaluate upadacitinib efficacy and safety dose response in Japanese patients with active RA and an inadequate response to conventional synthetic DMARDs (csDMARDs). METHODS: This was a multicentre, phase IIb/III, dose-ranging study conducted in Japan, in which patients on previously sta...

Subject

Medicine

Rheumatoid arthritis

Placebo

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!